NCT06739096

Brief Summary

The aim of this randomized, double-blind, placebo-controlled study was to evaluate the effects of shortwave diathermy therapy on pain, grip strength, and functionality in patients with hand osteoarthritis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

November 26, 2025

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

December 8, 2024

Last Update Submit

November 19, 2025

Conditions

Keywords

hand osteoarthritisshort wave diathermyshortwave diathermy

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale

    0-10 scale. Higher scores represent more severe pain.

    At the beginning of treatment (week 0), at the end of treatment (week 3) and 12 weeks after the end of treatment (week 15)

  • hand dynamometer and pinchmeter measurements

    Measurements will be made three times for each fine force on both hands and the average values will be recorded in kg.

    At the beginning of treatment (week 0), at the end of treatment (week 3) and 12 weeks after the end of treatment (week 15)

Secondary Outcomes (2)

  • Duruöz Hand Index

    At the beginning of treatment (week 0), at the end of treatment (week 3) and 12 weeks after the end of treatment (week 15)

  • Moberg Pickup Test

    At the beginning of treatment (week 0), at the end of treatment (week 3) and 12 weeks after the end of treatment (week 15)

Study Arms (2)

Short Wave Diathermy + Exercise

EXPERIMENTAL
Device: Short Wave DiathermyOther: Exercise

Sham Short Wave Diathermy + Exercise

SHAM COMPARATOR
Other: ExerciseDevice: Sham Short Wave Diathermy

Interventions

Shortwave diathermy (SWT) is a form of electromagnetic therapy that causes the movement of ions, the disruption of molecules, and the generation of eddy currents, which ultimately produce heat in deep tissue. Its claimed mechanism of action includes inducing an anti-inflammatory response, reducing joint stiffness, stimulating connective tissue repair, and reducing muscle spasm and pain.

Short Wave Diathermy + Exercise

range of motion, strengthening and stretching exercises

Sham Short Wave Diathermy + ExerciseShort Wave Diathermy + Exercise

Sham protocol

Sham Short Wave Diathermy + Exercise

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be between 35-75 years old
  • Diagnosis of hand osteoarthritis according to the ACR 1990 Criteria

You may not qualify if:

  • Chronic inflammatory diseases (rheumatoid arthritis, seronegative spondyloarthropathy, gout, hemochramatosis, etc.)
  • Malignancy
  • Having uncontrolled systemic disease (cardiovascular, pulmonary, hematologic, hepatic, renal, endocrinologic)
  • Synovitis, tenosynovitis, entrapment neuropathy, contracture, open wound in hand/wrist
  • History of hand fracture and/or operation
  • Regular use of nonsteroidal anti-inflammatory drugs in the last three weeks
  • Regular use of diaserin, chondroitin sulfate, glucosamine in the last three months
  • Body Mass Index greater than 35

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haydarpaşa Numune Training and Research Hospital

Istanbul, Istanbul, 34668, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Exercise

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Nilgün Mesci, Assoc. Prof., MD

    Haydarpaşa Numune Training and Research Hospital

    STUDY CHAIR
  • Duygu Geler Külcü, Prof., MD

    Haydarpaşa Numune Training and Research Hospital

    STUDY DIRECTOR
  • Sibel Süzen Özbayrak, MD

    Haydarpaşa Numune Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 8, 2024

First Posted

December 18, 2024

Study Start

March 18, 2024

Primary Completion

February 18, 2025

Study Completion

February 28, 2026

Last Updated

November 26, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Safety concerns

Locations